ClinicalTrials.gov record
Terminated Phase 4 Interventional Results available

Outpatient Physical Therapy Intervention in Subjects With Parkinson's Disease Currently Using APOKYN®

ClinicalTrials.gov ID: NCT02549573

Public ClinicalTrials.gov record NCT02549573. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 11:44 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Outpatient Physical Therapy Intervention in Subjects With Parkinson's DiseaseCurrently Using APOKYN®: A Phase IV Study of Outcome Assessments of Physical Therapy in Subjects in an "On" Versus "End-of-Dose-Off" Motor State

Study identification

NCT ID
NCT02549573
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 4
Lead sponsor
MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals
Industry
Enrollment
13 participants

Conditions and interventions

Interventions

  • APOKYN Drug
  • Physical Therapy Behavioral

Drug · Behavioral

Eligibility (public fields only)

Age range
18 Years to 78 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2015
Primary completion
Nov 30, 2016
Completion
Nov 30, 2016
Last update posted
Aug 31, 2023

2016

United States locations

U.S. sites
12
U.S. states
9
U.S. cities
12
Facility City State ZIP Site status
Not listed Phoenix Arizona 85013
Not listed Scottsdale Arizona 85258
Not listed Loma Linda California 92354
Not listed Sunnyvale California 94085
Not listed Orlando Florida 32803
Not listed Foxborough Massachusetts 02035
Not listed Cleveland Ohio 44106
Not listed Tulsa Oklahoma 74136
Not listed Hershey Pennsylvania 17033
Not listed Austin Texas 78746
Not listed Kirkland Washington 98034
Not listed Tacoma Washington 98409

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02549573, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 31, 2023 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02549573 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →